SMTL ID : 8a32.1 (1 other biounit)

p53 cancer mutant Y220C in complex with iodophenol-based small-molecule stabilizer JC769

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.47 Å

Oligo State

monomer

Ligands

1 x KVA: 4-[3,4-bis(fluoranyl)pyrrol-1-yl]-3,5-bis(iodanyl)-2-oxidanyl-benzoic acid(Non-covalent)

KVA.1: 13 residues within 4Å: Chain A: F.16, L.52, V.54, T.57, P.58, V.64, C.127, E.128, P.129, P.130, D.135, T.137, L.164 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:T.57, A:P.129 Hydrogen bonds: A:D.135 Water bridges: A:V.54, A:D.135 Halogen bonds: A:L.52

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 2 residues within 4Å: Chain A: N.38, S.176 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.38, A:S.176

1 x ZN: ZINC ION(Non-covalent)

ZN.3: 4 residues within 4Å: Chain A: C.83, H.86, C.145, C.149 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.83, A:H.86, A:C.145, A:C.149

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Stephenson Clarke, J.R. et al., Discovery of Nanomolar-Affinity Pharmacological Chaperones Stabilizing the Oncogenic p53 Mutant Y220C. Acs Pharmacol Transl Sci (2022)

Release Date

2022-11-30

Peptides

Cellular tumor antigen p53: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cellular tumor antigen p53

Related Entries With Identical Sequence